MEREDITH DEWITTE: Open Payments
NPI 1891294419 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 18 payments from 11 companies in 2025. Trend: 2023 $205 · 2024 $788 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 2 | $114 |
| Merck Sharp & Dohme LLC | 4 | $108 |
| Eisai Inc. | 2 | $62 |
| ABBVIE INC. | 3 | $55 |
| Integra LifeSciences Corporation | 1 | $41 |
| Tempus AI, Inc | 1 | $29 |
| Caris MPI, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Davol Inc. | 1 | $20 |
| AtriCure, Inc. | 1 | $19 |
Products named: MYRISK, KEYTRUDA, Lenvima, ELAHERE, LYNPARZA, CODMAN CERTAS, XT CDX, MI CANCER SEEK.
Industry payments across OK — which companies pay providers there.
